102 related articles for article (PubMed ID: 2457222)
1. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
[TBL] [Abstract][Full Text] [Related]
2. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP
Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607
[TBL] [Abstract][Full Text] [Related]
3. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug.
Urien S; Pinquier JL; Paquette B; Chaumet-Riffaud P; Kiechel JR; Tillement JP
J Pharmacol Exp Ther; 1987 Jul; 242(1):349-53. PubMed ID: 2956411
[TBL] [Abstract][Full Text] [Related]
4. Effects of isradipine and darodipine on serotonergic system of the rat brain.
Gaggi R; Dall'Olio R; Roncada P; Gianni AM
Pharmacol Biochem Behav; 1995; 51(2-3):183-7. PubMed ID: 7545305
[TBL] [Abstract][Full Text] [Related]
5. Determination of isradipine and its pyridine metabolite in serum by capillary column gas chromatography with nitrogen-selective detection.
Christensen HR; Angelo HR; Skajaa K
J Chromatogr; 1992 Feb; 574(1):161-5. PubMed ID: 1385820
[TBL] [Abstract][Full Text] [Related]
6. Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system.
Gaggi R; Dall'Olio R; Roncada P; Gianni AM
Gen Pharmacol; 1995 Mar; 26(2):303-8. PubMed ID: 7590078
[TBL] [Abstract][Full Text] [Related]
7. [Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications].
Wachowiak R; Strach B; Lopatka P
Arch Med Sadowej Kryminol; 2005; 55(1):47-54. PubMed ID: 15984121
[TBL] [Abstract][Full Text] [Related]
8. Nicanartine improves in vitro resistance of lipoproteins to oxidation.
Dailly E; Urien S; Wülfroth P; Tillement JP
Pharm Res; 1996 Mar; 13(3):457-61. PubMed ID: 8692742
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective binding of isradipine to human plasma proteins.
Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
[TBL] [Abstract][Full Text] [Related]
10. Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats.
Fadda F; Garau B; Colombo G; Gessa GL
Alcohol Clin Exp Res; 1992 Jun; 16(3):449-52. PubMed ID: 1385678
[TBL] [Abstract][Full Text] [Related]
11. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
[TBL] [Abstract][Full Text] [Related]
12. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
Niwa T; Tokuma Y; Noguchi H
Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
[TBL] [Abstract][Full Text] [Related]
13. Improved radioreceptor assay for the determination of plasma levels of dihydropyridine calcium channel blockers in humans.
Quennedey MC; Ehrhardt JD; Welsch M; Rouot B; Schwartz J
Ther Drug Monit; 1989 Sep; 11(5):598-606. PubMed ID: 2530665
[TBL] [Abstract][Full Text] [Related]
14. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
Zini R; Morin D; Jouenne P; Tillement JP
Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein binding and erythrocyte partitioning of nicardipine in vitro.
Urien S; Albengres E; Comte A; Kiechel JR; Tillement JP
J Cardiovasc Pharmacol; 1985; 7(5):891-8. PubMed ID: 2413297
[TBL] [Abstract][Full Text] [Related]
16. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum.
Morin D; Simon N; Deprés-Brummer P; Lévi F; Tillement JP; Urien S
Pharmacology; 1997 May; 54(5):271-5. PubMed ID: 9380773
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and dialysability of isradipine in chronic haemodialysis patients.
Schönholzer K; Marone C
Eur J Clin Pharmacol; 1992; 42(2):231-3. PubMed ID: 1535593
[TBL] [Abstract][Full Text] [Related]
18. Binding of bornaprolol to human serum proteins and blood cells.
Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
[TBL] [Abstract][Full Text] [Related]
19. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing isradipine and amlodipine binding to human plasma lipoproteins.
Oravcova J; Sojkova D; Fetkovska N; Trnovec T
Blood Press Suppl; 1994; 1():61-4. PubMed ID: 8205304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
